Alveolar macrophages: wielding the double-edged sword of inflammation - PubMed (original) (raw)

Editorial

. 2003 Jan 15;167(2):103-4.

doi: 10.1164/rccm.2210007.

• PMID: 12524246
• DOI: 10.1164/rccm.2210007

Editorial

Alveolar macrophages: wielding the double-edged sword of inflammation

Jeffrey B Rubins. Am J Respir Crit Care Med. 2003.

No abstract available

PubMed Disclaimer

Comment on

• Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.
  Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T. Knapp S, et al. Am J Respir Crit Care Med. 2003 Jan 15;167(2):171-9. doi: 10.1164/rccm.200207-698OC. Epub 2002 Sep 25. Am J Respir Crit Care Med. 2003. PMID: 12406830

Similar articles

• Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.
  Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T. Knapp S, et al. Am J Respir Crit Care Med. 2003 Jan 15;167(2):171-9. doi: 10.1164/rccm.200207-698OC. Epub 2002 Sep 25. Am J Respir Crit Care Med. 2003. PMID: 12406830
• Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.
  Meyer M, Huaux F, Gavilanes X, van den Brûle S, Lebecque P, Lo Re S, Lison D, Scholte B, Wallemacq P, Leal T. Meyer M, et al. Am J Respir Cell Mol Biol. 2009 Nov;41(5):590-602. doi: 10.1165/rcmb.2008-0155OC. Epub 2009 Feb 24. Am J Respir Cell Mol Biol. 2009. PMID: 19244203
• Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.
  Malur A, Mccoy AJ, Arce S, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. Malur A, et al. J Immunol. 2009 May 1;182(9):5816-22. doi: 10.4049/jimmunol.0803504. J Immunol. 2009. PMID: 19380830
• Acute lung injury: how the lung inflammatory response works.
  Ward PA. Ward PA. Eur Respir J Suppl. 2003 Sep;44:22s-23s. doi: 10.1183/09031936.03.00000703a. Eur Respir J Suppl. 2003. PMID: 14582896 Review. No abstract available.
• Of mice and men: innate immunity in pneumococcal pneumonia.
  Calbo E, Garau J. Calbo E, et al. Int J Antimicrob Agents. 2010 Feb;35(2):107-13. doi: 10.1016/j.ijantimicag.2009.10.002. Epub 2009 Dec 14. Int J Antimicrob Agents. 2010. PMID: 20005681 Review.

Cited by

• Lipid nanoparticle encapsulated large peritoneal macrophages migrate to the lungs via the systemic circulation in a model of clodronate-mediated lung-resident macrophage depletion.
  Oza D, Ivich F, Pace J, Yu M, Niedre M, Amiji M. Oza D, et al. Theranostics. 2024 Apr 8;14(6):2526-2543. doi: 10.7150/thno.91062. eCollection 2024. Theranostics. 2024. PMID: 38646640 Free PMC article.
• IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections.
  Kheir S, Villeret B, Garcia-Verdugo I, Sallenave JM. Kheir S, et al. Mol Ther. 2022 Jan 5;30(1):355-369. doi: 10.1016/j.ymthe.2021.08.007. Epub 2021 Aug 8. Mol Ther. 2022. PMID: 34371178 Free PMC article.
• Dual Substance Use of Electronic Cigarettes and Alcohol.
  Wetzel TJ, Wyatt TA. Wetzel TJ, et al. Front Physiol. 2020 Nov 2;11:593803. doi: 10.3389/fphys.2020.593803. eCollection 2020. Front Physiol. 2020. PMID: 33224040 Free PMC article. Review.
• Mitochondrial damage pathways in ventilator induced lung injury (VILI): an update.
  Parker JC. Parker JC. J Lung Health Dis. 2018;2(2):18-22. Epub 2018 Apr 18. J Lung Health Dis. 2018. PMID: 30123891 Free PMC article.
• Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.
  Fan Y, Yang Z. Fan Y, et al. Pharmaceutics. 2022 Jun 2;14(6):1193. doi: 10.3390/pharmaceutics14061193. Pharmaceutics. 2022. PMID: 35745766 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.